The Philadelphia chromosome, arising as a consequence of the t(9;22) t
ranslocation, is one of the most frequent and certainly the most known
cytogenetic abnormality present in human hematological malignancies.
Unlike the vast majority of the other translocations, its presence is
not restricted to a specific leukemia phenotype, but is found associat
ed with chronic myelogenous leukemia as well as with a large percentag
e of acute lymphoblastic leukemias, particularly in elderly patients.
Although its molecular counterpart is always represented by a rearrang
ement between the BCR and the ABL genes, this shows a certain degree o
f molecular variability. The pathogenetic relationship with the differ
ent leukemia phenotypes which have been found to be associated still a
waits to be fully elucidated. However, a number of old and more recent
observations seem to suggest that not only qualitative differences in
the type of BCR/ABL proteins expressed, but also quantitative variati
ons in their total level within the cells may have an important role i
n determining the leukemia phenotype.